Published 08:21 IST, February 17th 2021
Johnson & Johnson files for COVID-19 vaccine approval from EU
Janssen vaccine candidate can prevent ‘moderate’ to ‘severe’ COVID-19 infection, 28 days after the dose was administered, Johnson & Johnson said in a filing.
null | Image:
self
Advertisement
08:21 IST, February 17th 2021